Total Payments
$2,427
2024 Payments
$310.01
Companies
22
Transactions
56
Medicare Patients
3,238
Medicare Billing
$310,361
Payment Breakdown by Category
Food & Beverage$1,515 (62.4%)
Other$911.92 (37.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,515 | 55 | 62.4% |
| Long term medical supply or device loan | $911.92 | 1 | 37.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec USA, Inc. | $911.92 | 1 | $0 (2022) |
| ABBVIE INC. | $380.91 | 13 | $0 (2024) |
| TISSUETECH, INC. | $257.59 | 8 | $0 (2021) |
| Ocular Therapeutix, Inc. | $135.98 | 1 | $0 (2021) |
| BIOTISSUE HOLDINGS, INC. | $125.78 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $74.08 | 3 | $0 (2023) |
| Genentech USA, Inc. | $52.74 | 3 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $52.11 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $51.90 | 2 | $0 (2023) |
| Allergan Inc. | $49.36 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.01 | 11 | ABBVIE INC. ($235.37) |
| 2023 | $295.74 | 11 | BIOTISSUE HOLDINGS, INC. ($71.19) |
| 2022 | $1,113 | 9 | Carl Zeiss Meditec USA, Inc. ($911.92) |
| 2021 | $247.15 | 6 | Ocular Therapeutix, Inc. ($135.98) |
| 2020 | $44.83 | 2 | TissueTech, Inc. ($23.11) |
| 2019 | $57.44 | 3 | Aerie Pharmaceuticals, Inc. ($23.82) |
| 2018 | $202.06 | 8 | TissueTech, Inc. ($112.09) |
| 2017 | $156.74 | 6 | TissueTech, Inc. ($70.27) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: EYE CARE | ||||||
| 08/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: EYE CARE | ||||||
| 06/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: EYE CARE | ||||||
| 06/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/07/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/23/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: EYE CARE | ||||||
| 04/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: EYE CARE | ||||||
| 02/09/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: EYE CARE | ||||||
| 01/04/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: EYE CARE | ||||||
| 11/17/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: EYE CARE | ||||||
| 11/10/2023 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $47.17 | General |
| Category: Ophthalmology | ||||||
| 09/05/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Ophthalmology | ||||||
| 07/26/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Ophthalmology | ||||||
| 07/12/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: DRY EYE | ||||||
| 06/26/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 05/15/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Ophthalmology | ||||||
| 05/02/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: TEPEZZA | ||||||
| 04/29/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/27/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: EYE CARE | ||||||
| 03/20/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 11/22/2022 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/22/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 10/08/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.72 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 761 | 921 | $159,960 | $73,944 |
| 2022 | 7 | 841 | 1,070 | $184,455 | $80,974 |
| 2021 | 7 | 868 | 1,159 | $195,955 | $91,212 |
| 2020 | 8 | 768 | 945 | $157,575 | $64,231 |
Total Patients
3,238
Total Services
4,095
Medicare Billing
$310,361
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 401 | 477 | $95,400 | $49,800 | 52.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 102 | 139 | $17,375 | $10,568 | 60.8% |
| 92134 | Imaging of retina | Office | 2023 | 105 | 144 | $18,000 | $5,231 | 29.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 59 | 64 | $14,720 | $3,617 | 24.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 17 | 17 | $3,825 | $2,205 | 57.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 61 | 64 | $8,000 | $1,981 | 24.8% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 16 | $2,640 | $543.02 | 20.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 426 | 518 | $103,600 | $52,334 | 50.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 104 | 178 | $22,250 | $12,824 | 57.6% |
| 92134 | Imaging of retina | Office | 2022 | 101 | 155 | $19,375 | $5,328 | 27.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 68 | 71 | $16,330 | $3,540 | 21.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 26 | 26 | $5,850 | $3,088 | 52.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 71 | 77 | $9,625 | $2,360 | 24.5% |
| 92250 | Photography of the retina | Office | 2022 | 45 | 45 | $7,425 | $1,500 | 20.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 408 | 492 | $98,400 | $52,675 | 53.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 121 | 242 | $30,250 | $18,844 | 62.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 114 | 187 | $23,330 | $7,224 | 31.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 88 | 97 | $22,310 | $5,668 | 25.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 24 | 24 | $5,400 | $3,003 | 55.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 69 | 73 | $9,125 | $2,362 | 25.9% |
| 92250 | Photography of the retina | Office | 2021 | 44 | 44 | $7,140 | $1,436 | 20.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 341 | 402 | $80,400 | $38,653 | 48.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 115 | 171 | $21,375 | $11,012 | 51.5% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 91 | 137 | $17,125 | $4,573 | 26.7% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 65 | 75 | $17,250 | $4,100 | 23.8% |
About Dr. David Heiden, MD
Dr. David Heiden, MD is a Ophthalmology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053312108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Heiden, MD has received a total of $2,427 in payments from pharmaceutical and medical device companies, with $310.01 received in 2024. These payments were reported across 56 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,515).
As a Medicare-enrolled provider, Heiden has provided services to 3,238 Medicare beneficiaries, totaling 4,095 services with total Medicare billing of $310,361. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location San Francisco, CA
- Active Since 08/10/2005
- Last Updated 07/13/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1053312108
Products in Payments
- CLARUS (Device) $911.92
- DURYSTA (Drug) $332.76
- Prokera (Device) $223.59
- PROKERA (Device) $159.78
- DEXTENZA (Drug) $135.98
- XIIDRA (Drug) $89.58
- LUMIGAN (Drug) $61.61
- TEPEZZA (Drug) $51.90
- enVista MX60 IOL (Device) $47.17
- EYLEA (Biological) $41.87
- Rocklatan (Drug) $37.90
- Lucentis (Biological) $33.56
- Syfovre (Drug) $30.39
- ACTHAR (Biological) $25.26
- TEPEZZA (Biological) $25.07
- LOTEMAX GEL (Drug) $23.53
- TYRVAYA (Drug) $23.45
- PROLENSA (Drug) $23.36
- Cequa (Drug) $21.47
- Rhopressa (Drug) $21.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Francisco
Dr. Daniel Schwartz, M.d, M.D
Ophthalmology — Payments: $8.0M
Ophthalmology $8.0M
Shan Lin, Md, MD
Ophthalmology — Payments: $437,860
Ophthalmology $437,860
Dr. Eugene De Juan, Md, MD
Ophthalmology — Payments: $349,911
Ophthalmology $349,911
Dr. H Tanaka, Md, MD
Ophthalmology — Payments: $326,711
Ophthalmology $326,711
Dr. Jay Stewart, Md, MD
Ophthalmology — Payments: $295,001
Ophthalmology $295,001
Dr. Scott So, M.d, M.D
Ophthalmology — Payments: $172,800
Ophthalmology $172,800